Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21736516 | 0.98 | NPY5R (0.34) | NPY5RESR1ESR2HTR2C | |
| SCHEMBL21735856 | 0.95 | NPY5R (0.33) | NPY5RESR1ESR2HTR2CKDM4E | |
| SCHEMBL21735892 | 0.94 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL20669823 | 0.93 | PDE4A (0.31) | ESR1ESR2 | |
| SCHEMBL21736536 | 0.93 | NPY5R (0.34) | NPY5RESR1ESR2HTR2C | |
| SCHEMBL20669789 | 0.91 | LIMK1 (0.37) | NPY5RESR1ESR2 | |
| SCHEMBL20670135 | 0.91 | TUBB4A (0.36) | HTR2C | |
| SCHEMBL21736104 | 0.90 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL21736049 | 0.89 | TUBB4A (0.34) | NPY5R | |
| SCHEMBL21736198 | 0.89 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | NPY5R 4334/4885ESR1 72/4885ESR2 428/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | NPY5R 4334/4885ESR1 72/4885ESR2 428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.